UK markets close in 4 hours 38 minutes

Why Moderna Stock Jumped 10.7% Today

Joe Tenebruso, The Motley Fool
Why Moderna Stock Jumped 10.7% Today

Shares of Moderna (NASDAQ: MRNA) rose more than 10% on Friday after the biotechnology company announced the commencement of its Phase 2 study for its novel coronavirus vaccine. Moderna said the first participants in each age group of its Phase 2 study have received doses of its experimental COVID-19 vaccine, mRNA-1273. Moderna is seeking to enroll 600 healthy participants, including 300 people aged 18-55 and 300 people older than 55.